Title |
In vitro avarol does affect the growth of Candida sp.
|
---|---|
Published in |
Natural Product Research, September 2015
|
DOI | 10.1080/14786419.2015.1091454 |
Pubmed ID | |
Authors |
Boris Pejin, Ana Ciric, Dejan Markovic, Giuseppina Tommonaro, Marina Sokovic |
Abstract |
This work extends in vitro screening of antimicrobial activity of avarol, the marine natural product firstly isolated from the Mediterranean sponge Dysidea avara. Its anticandidial activity was evaluated by microdilution method against eight Candida strains, two ATCC and six clinical ones. At a different extent this compound was proven to be active against all the strains tested (MIC 0.8-6.0 μg/mL and MFC 1.6-12.0 μg/mL, respectively). According to the best of our knowledge, this is the first report on avarol activity towards any yeast strain which may be of relevance for Alzheimer's disease. Indeed, avarol derivatives showing moderate AChE activity should be screened for anticandidial activity both in vitro and in vivo. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
France | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Serbia | 2 | 14% |
Unknown | 12 | 86% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 3 | 21% |
Researcher | 2 | 14% |
Librarian | 1 | 7% |
Professor | 1 | 7% |
Other | 1 | 7% |
Other | 2 | 14% |
Unknown | 4 | 29% |
Readers by discipline | Count | As % |
---|---|---|
Chemistry | 2 | 14% |
Medicine and Dentistry | 2 | 14% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 7% |
Biochemistry, Genetics and Molecular Biology | 1 | 7% |
Earth and Planetary Sciences | 1 | 7% |
Other | 3 | 21% |
Unknown | 4 | 29% |